Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1504 participants.

Also called NCT05066620

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,504 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05066620
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05066620. Randomized; quadruple masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2024-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial
Condition
Intracerebral Hemorrhage
Intervention (Drug)
Chinese herbal medicine FYTF-919
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)
Collaborator
The George Institute (class: other)

Record details

Record id
cardio:ct-nct05066620
Content hash
f80310e6847177d08d75ad15548144022e71200b0759a1d36050d31e4369f1ae